Producing proteins in transgenic plants and animals

Current Opinion in Biotechnology

Volumn 12, Issue 4, 2001, Pages 411-418

  Larrick, James W ^a,b   Thomas, David W ^b  

^a Planet Biotechnology   (United States)

^b Palo Alto Institute of Molecular Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; CAPSID PROTEIN; CHOLERA TOXIN; COLLAGEN; ERYTHROPOIETIN; GROWTH HORMONE; HEPATITIS B SURFACE ANTIGEN; HIRUDIN; IMMUNOGLOBULIN G; LACTOFERRIN; PROTEIN SLGA; RABIES VACCINE; RECOMBINANT PROTEIN; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; VACCINE;

BIOREACTOR; GENE SILENCING; GENETIC TRANSCRIPTION; GLYCOSYLATION; HUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; TECHNOLOGY; TRANSGENIC ANIMAL; TRANSGENIC PLANT;

ANIMALIA; MIRIDAE;

EID: 0035423688     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(00)00236-6     Document Type: Review

References (90)

1. Generation and assembly of secretory antibodies in plants
2. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans
3. A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes
4. Expression of hepatitis B surface antigen in transgenic plants
5. Immunogenicity of transgenic plant-derived hepatitis B surface antigen
6. Production of hepatitis B surface antigen in transgenic plants for oral immunization
7. Expression of Norwalk virus capsid protein in transgenic tobacco and its oral immunogenicity in mice
8. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato
9. Oral immunization with a recombinant bacterial antigen produced in transgenic plants
10. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): Potatoes expressing a synthetic LT-B gene
11. Expression of cholera toxin B subunit oligomers in transgenic plants
12. Efficacy of a food plant-based oral cholera toxin B subunit vaccine
13. Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance
14. Plant-derived vaccine protects target animals against a viral disease
15. An overview of a feasibility study for the production of industrial enzymes in transgenic alfalfa
16. Production of a diagnostic monoclonal antibody in perennial alfalfa plants
17. Production of recombinant proteins in transgenic plants: Practical considerations
18. Processing of transgenic corn seed and its effect on the recovery of recombinant β-glucuronidase
19. Production and purification of two recombinant proteins from transgenic corn
20. Prospects and progress in the production of foreign proteins and peptides in transgenic plants
21. Antibody production in transgenic plants
22. Molecular farming of industrial proteins from transgenic maize
23. Production of antibodies in transgenic plants
24. Feasibility of antibody production in plants for human therapeutic use
25. Plant-based production of xenogenic proteins
26. High-level production and long-term storage of engineered antibodies in transgenic tobacco seeds
27. The production of recombinant proteins in transgenic barley grains
28. Efficient production of transgenic cassava using negative and positive selection
29. A promoter from sugarcane bacilliform badnavirus drives transgene expression in banana and other monocot and dicot plants
30. High-yield production of a human therapeutic protein in tobacco chloroplasts
31. Expression of cholera toxin B subunit oligomers in transgenic tobacco chloroplasts
32. Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals
33. Efficient expression of foreign proteins in roots from tobravirus vectors
34. A novel strategy for the expression of foreign genes from plant virus vectors
35. Expression of murine adenosine deaminase (ADA) in transgenic maize
36. N-Glycosylation of a mouse IgG expressed in transgenic tobacco plants
37. Involvement of carbohydrate epitopes in the IgE response of celery-allergic patients
38. Role of complex asparagine-linked glycans in the allergenicity of plant glycoproteins
39. Specific IgE without clinical allergy
40. Specific IgE to cross-reactive carbohydrate determinants strongly affects the in vitro diagnosis of allergic diseases
41. Poor biologic activity of cross-reactive IgE directed to carbohydrate determinants of glycoproteins
42. Galactose-extended glycans of antibodies produced by transgenic plants
43. Vicilin with carboxy-terminal KDEL is retained in the endosplasmic reticulum and accumulates to high levels in leaves of transgenic plants
44. Purification, cDNA cloning, and expression of GDP-L-Fuc:Asn-linked GlcNAcα1,3-fucosyltransferase from mung beans
45. Transcriptional gene silencing in plants: Targets, inducers and regulators
46. Post-transcriptional gene silencing in cultured rice cells
47. Plants as bioreactors for protein production: Avoiding the problem of transgene silencing
48. Use of matrix attachment regions (MARs) to minimize transgene silencing
49. HC-Pro suppression of transgene silencing eliminates the small RNAs but not transgene methylation or the mobile signal
50. Virus-encoded suppressor of posttranscriptional gene silencing targets a maintenance step in the silencing pathway
51. Release of epigenetic gene silencing by trans-acting mutations in Arabidopsis
52. Medical molecular farming: Production of antibodies, biopharmaceuticals and edible vaccines in plants
53. Regulation of protein traffic in polarized epithelial cells: The polymeric immunoglobulin receptor model
54. Commercial production of avidin from transgenic maize: Characterization of transformant, production, processing, extraction and purification
55. Expression of full-length bioactive antimicrobial human lactoferrin in potato plants
56. Triple helix assembly and processing of human collagen produced in transgenic tobacco plants
57. Structural requirements of oleosin domains for subcellular targeting to the oilbody
58. Development of oral vaccines for human use
59. Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes
60. Human respiratory syncytial virus vaccine antigen produced in plants
61. High-yield expression of a viral peptide vaccine in transgenic plants
62. Plant-derived measles virus hemagglutinin protein induces neutralizing antibodies in mice
63. Immunogenicity of porcine transmissible gastroenteritis virus spike protein expressed in plants
64. A plant-derived edible vaccine against hepatitis B virus
65. Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1
66. Transgenic milk as a method for the production of recombinant antibodies
67. Urine as a substitute for milk?
68. Introduction of the human growth hormone gene into the guinea pig mammary gland by in vivo transfection promotes sustained expression of human growth hormone in the milk throughout lactation
69. Production of calves by transfer of nuclei from cultured somatic cells obtained from Japanese black bulls
70. Long-term culture and characterization of goat primordial germ cells
71. Viable offspring derived from fetal and adult mammalian cells
72. Nuclear transfer in cattle using colostrum-derived mammary gland epithelial cells and ear-derived fibroblast cells
73. Cloning of calves from various somatic cell types of male and female adult, newborn and fetal cows
74. Production of cloned pigs from in vitro systems
75. Birth of mice after nuclear transfer by electrofusion using tail tip cells
76. Cloned pigs produced by nuclear transfer from adult somatic cells
77. Production of gene-targeted sheep by nuclear transfer from culture somatic cell
78. Clinical and pathologic features of cloned transgenic calves and fetuses (13 case studies)
79. Development of bovine embryo-derived clones after increasing rounds of nuclear recycling
80. Analysis of telomere lengths in cloned sheep
81. Telomerase activity in early bovine embryos derived from parthenogenetic activation and nuclear transfer
82. Reprogramming of telomerase activity and rebuilding of telomere length in cloned cattle
83. Extension of cell life-span and telomere length in animals cloned from senescent somatic cells
84. Recombinant human α-glucosidase from rabbit milk in Pompe patients
85. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria
86. Technology evaluation: Transgenic antithrombin III (rhAT-III), Genzyme Transgenics
87. Lysostaphin expression in mammary glands confers protection against staphylococcal infection in transgenic mice
88. Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies
89. Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants
90. Immunization against rabies with plant-derived antigen